Role of Salbutamol in the Management of Transient Tachypnea of the New Born

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

TTN

Interventions

DRUG

Salbutamol (Ventolin®)

Randomized controlled trials

Trial Locations (1)

Khyber Teaching Hospital Peshawar Pakistan, Timergara

All Listed Sponsors

lead

Khyber Teaching Hospital

OTHER

NCT06921291 - Role of Salbutamol in the Management of Transient Tachypnea of the New Born | Biotech Hunter | Biotech Hunter